Used primarily in pharmaceutical research, this compound is explored for its potential as a bioactive molecule, particularly in the development of central nervous system (CNS) drugs. Its structure suggests possible interactions with neurotransmitter systems, making it a candidate for studying treatments for neurological disorders such as depression, anxiety, or schizophrenia. Additionally, it may serve as a precursor or intermediate in synthesizing more complex therapeutic agents targeting specific receptors in the brain. Research is ongoing to evaluate its efficacy and safety in preclinical models.